IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

(2011) Francesco Marabita et al.   HEPATOLOGY

82 ASSOCIATION BETWEEN IL28B GENE VARIATION AND DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

(2011) Y. Asahina et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2011)   JOURNAL OF HEPATOLOGY

Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis

(2011) Tao Cai et al.   JOURNAL OF HEPATOLOGY

Antitumor activity of Type I and Type III interferons in BNL hepatoma model

(2010) Walid Abushahba et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response

(2010) Stefan Zeuzem et al.   CURRENT MEDICAL RESEARCH AND OPINION

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

(2010) Andri Rauch et al.   GASTROENTEROLOGY

Interferon   receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

(2010) B. Nalpas et al.   GUT

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

(2010) Andrew J. Muir et al.   HEPATOLOGY

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients

(2010) Hiromi Abe et al.   JOURNAL OF HEPATOLOGY

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC

(2010) Carlo Fabris et al.   JOURNAL OF HEPATOLOGY

IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques

(2010) Matthew P Morrow et al.   MOLECULAR THERAPY

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

(2009) M. P. Morrow et al.   BLOOD

Interferon-λ induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents

(2009) Quanhai Li et al.   EUROPEAN JOURNAL OF CANCER

Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

(2009) Erik H.C.J. Buster et al.   GASTROENTEROLOGY

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C

(2009) Paula Bonorino et al.   JOURNAL OF HEPATOLOGY

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C

(2009) Pierre-Yves Bochud et al.   JOURNAL OF HEPATOLOGY

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

(2009) Alfredo Alberti   LIVER INTERNATIONAL

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE